This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nearly half of these drugs were considered first in class or first in indication, and several were deemed clinically useful or to have high added therapeutic benefit by four health technology assessment organizations (HTAs) in Germany, Canada, or France. Benefit ratings by at least one of the four organizations were available for 38 drugs.
Each technology has its own unique properties, including the size and shape of the microthermal zones created, as well as different treatment protocols. The use of micro-focused ultrasound was introduced in 2009 to deliver heat to deep, subdermal connective tissue in focused zones. Micro-focused ultrasound.
He is “Professor of Genetics at Harvard Medical School and Director of PersonalGenomes.org , which provides the world's only open-access information on human Genomic, Environmental & Trait data ( GET ). His 1984 Harvard PhD included the first methods for direct genome sequencing, molecular multiplexing & barcoding. Matthew Liao.
I was lucky enough in 2009 to get on the board of the first direct-to-consumer genome company called Knome that George Church had co-founded. I had my own whole genome sequenced in 2009. But I did start reading molecular biology. I became very passionate about keeping up with antiaging science. We started talking about aging.
The estimated annual medical costs were roughly $173 billion in 2019 dollars. Using this estimate, medical costs for obese adults were $1,861 higher than those who had a healthy weight. In the U.S., the CDC 5 reports the prevalence of obesity in adults was 41.9% measured from 2017 to March 2020. This represented an increase from 30.5%
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content